Signaling in the basal ganglia:: Postsynaptic and presynaptic mechanisms

被引:35
作者
Fisone, Gilberto [1 ]
Hakansson, Kerstin [1 ]
Borgkvist, Anders [1 ]
Santini, Emanuela [1 ]
机构
[1] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden
关键词
DARPP-32; tyrosine hydroxylase; Parkinson's disease; levodopa; dyskinesia; adenosine; caffeine; haloperidol; motor activity;
D O I
10.1016/j.physbeh.2007.05.028
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The selection and execution of appropriate motor behavior result in large part from the ability of the basal ganglia to collect, integrate and feedback information coming from the cerebral cortex. The GABAergic medium spiny neurons (MSNs) of the striatum represent the main receiving station of the basal ganglia. These cells are innervated by excitatory glutamatergic fibers from cortex and thalamus, and modulatory dopaminergic fibers from the midbrain. MSNs comprise two populations of projection neurons, which give rise to the direct, striatonigral pathway, and indirect, striatopallidal pathway. Changes in transmission at the level MSNs affect the activity of thalamocortical projection neurons, thereby influencing motor behavior. For instance, the cardinal symptoms of Parkinson's disease, such as tremor, rigidity and bradykinesia, are caused by the selective degeneration of dopaminergic neurons originating in the substantia nigra pars compacta, which modulate the activity of MSNs in the dorsal striatum. The therapy for Parkinson's disease relies on the use of levodopa, but is hampered by neuroadaptive changes affecting dopaminergic and glutamatergic transmission in striatonigral neurons. MSNs are also the target of many psychoactive drugs. For example, caffeine affects motor activity by blocking adenosine receptors in the basal ganglia, thereby affecting neurotransmission in striatopallidal neurons. The present review focuses on studies performed in our laboratory, which provide a molecular framework to understand the effects on motor activity of adenosine and caffeine. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:8 / 14
页数:7
相关论文
共 36 条
[1]   Striatal fosB expression is causally linked with L-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease [J].
Andersson, M ;
Hilbertson, A ;
Cenci, MA .
NEUROBIOLOGY OF DISEASE, 1999, 6 (06) :461-474
[2]   Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia [J].
Aubert, I ;
Guigoni, C ;
Håkansson, K ;
Li, Q ;
Dovero, S ;
Barthe, N ;
Bioulac, BH ;
Gross, CE ;
Fisone, G ;
Bloch, B ;
Bezard, E .
ANNALS OF NEUROLOGY, 2005, 57 (01) :17-26
[3]   Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons [J].
Bibb, JA ;
Snyder, GL ;
Nishi, A ;
Yan, Z ;
Meijer, L ;
Fienberg, AA ;
Tsai, LH ;
Kwon, YT ;
Girault, JA ;
Czernik, AJ ;
Huganir, RL ;
Hemmings, HC ;
Nairn, AC ;
Greengard, P .
NATURE, 1999, 402 (6762) :669-671
[4]   Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5 [J].
Bibb, JA ;
Chen, JS ;
Taylor, JR ;
Svenningsson, P ;
Nishi, A ;
Snyder, GL ;
Yan, Z ;
Sagawa, ZK ;
Ouimet, CC ;
Nairn, AC ;
Nestler, EJ ;
Greengard, P .
NATURE, 2001, 410 (6826) :376-380
[5]   LONG-TERM POTENTIATION IN THE STRIATUM IS UNMASKED BY REMOVING THE VOLTAGE-DEPENDENT MAGNESIUM BLOCK OF NMDA RECEPTOR CHANNELS [J].
CALABRESI, P ;
PISANI, A ;
MERCURI, NB ;
BERNARDI, G .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1992, 4 (10) :929-935
[6]   Unilateral dopamine denervation blocks corticostriatal LTP [J].
Centonze, D ;
Gubellini, P ;
Picconi, B ;
Calabresi, P ;
Giacomini, P ;
Bernardi, G .
JOURNAL OF NEUROPHYSIOLOGY, 1999, 82 (06) :3575-3579
[7]   Persistent increase in olfactory type G-protein α subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease [J].
Corvol, JC ;
Muriel, MP ;
Valjent, E ;
Féger, J ;
Hanoun, N ;
Girault, JA ;
Hirsch, EC ;
Hervé, D .
JOURNAL OF NEUROSCIENCE, 2004, 24 (31) :7007-7014
[8]   THE DOPAMINE-D2 RECEPTOR - 2 MOLECULAR-FORMS GENERATED BY ALTERNATIVE SPLICING [J].
DALTOSO, R ;
SOMMER, B ;
EWERT, M ;
HERB, A ;
PRITCHETT, DB ;
BACH, A ;
SHIVERS, BD ;
SEEBURG, PH .
EMBO JOURNAL, 1989, 8 (13) :4025-4034
[9]   DARPP-32: Regulator of the efficacy of dopaminergic neurotransmission [J].
Fienberg, AA ;
Hiroi, N ;
Mermelstein, PG ;
Song, WJ ;
Snyder, GL ;
Nishi, A ;
Cheramy, A ;
O'Callaghan, JP ;
Miller, DB ;
Cole, DG ;
Corbett, R ;
Haile, CN ;
Cooper, DC ;
Onn, SP ;
Grace, AA ;
Ouimet, CC ;
White, FJ ;
Hyman, SE ;
Surmeier, DJ ;
Girault, JA ;
Nestler, EJ ;
Greengard, P .
SCIENCE, 1998, 281 (5378) :838-+
[10]   MOLECULAR-CLONING OF THE RAT ADENOSINE-A2 RECEPTOR - SELECTIVE COEXPRESSION WITH D2-DOPAMINE RECEPTORS IN RAT STRIATUM [J].
FINK, JS ;
WEAVER, DR ;
RIVKEES, SA ;
PETERFREUND, RA ;
POLLACK, AE ;
ADLER, EM ;
REPPERT, SM .
MOLECULAR BRAIN RESEARCH, 1992, 14 (03) :186-195